Stay updated on CTX001 in Severe Sickle Cell: Clinical Trial
Sign up to get notified when there's something new on the CTX001 in Severe Sickle Cell: Clinical Trial page.

Latest updates to the CTX001 in Severe Sickle Cell: Clinical Trial page
- Check3 days agoChange DetectedThe page revision label was updated to v3.6.4, signaling a minor update to the page that does not modify study details or user-facing content.SummaryDifference0.0%

- Check10 days agoNo Change Detected
- Check17 days agoChange DetectedThe study record now shows Results Submitted instead of No Results Posted. This indicates that outcome data are being prepared for posting and will be available in the near future.SummaryDifference0.0%

- Check24 days agoChange DetectedThe page revision was updated from v3.6.2 to v3.6.3, indicating a minor update to the study record's version metadata. This change appears to be a backend or documentation update rather than a modification to study content or visible data.SummaryDifference0.0%

- Check31 days agoChange DetectedThe page's revision label was updated from v3.6.0 to v3.6.2, signaling a newer build of the page. It represents a technical version update rather than a change to the study data.SummaryDifference0.0%

- Check45 days agoChange DetectedThe study page now indicates that recruitment has ended ('No longer looking for participants'), and introduces new help/navigation items (How to Read a Study Record, Common Questions, How to Join a Study) along with a header formatting change for Intervention/Treatment and a new Revision tag (v3.6.0).SummaryDifference0.4%

- Check53 days agoChange DetectedThe page's revision label updated from v3.5.4 to v3.5.5, signaling a new revision of the study page content. This change represents a minor update to the page metadata and does not alter the study data or listed details.SummaryDifference0.0%

Stay in the know with updates to CTX001 in Severe Sickle Cell: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CTX001 in Severe Sickle Cell: Clinical Trial page.